A More Radical Solution

Author(s): Peter J. Lachmann.

Journal Name: Reviews on Recent Clinical Trials

Volume 10 , Issue 1 , 2015

Submit Manuscript
Submit Proposal


The current modifications to licensing procedures still leave a basically flawed system in place. A more radical solution is proposed that involves dispensing with Phase 3 trials and making medicines available at the end of Phase 2 to those who are fully informed of the potential risks and benefits and wish to take part in this novel procedure. The advantages include a shorter development time, lower development costs and allowing smaller companies to take medicines to the clinic. The principal obstacle is that medicines are subject to strict liability rather than the tort of negligence – and this will have to be amended in due course.

Keywords: Phase 3, strict liability.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Page: [25 - 27]
Pages: 3
DOI: 10.2174/1574887110666150430151051

Article Metrics

PDF: 18